Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Asset purchase
1.2.3 Assignment
1.2.4 Co-development
1.2.5 Co-market
1.2.6 Co-promotion
1.2.7 Collaborative R&D
1.2.8 Contract service
1.2.9 CRADA
1.2.10 Cross-licensing
1.2.11 Others
1.3 Market by Application
1.3.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Industry sector
1.3.3 Therapy areas
1.3.4 Technology type
1.3.5 Deal components
1.3.6 Financial terms
1.3.7 Stage of development
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Perspective (2018-2033)
2.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Growth Trends by Region
2.2.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Dynamics
2.3.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Industry Trends
2.3.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Drivers
2.3.3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Challenges
2.3.4 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics by Players
3.1.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Concentration Ratio
3.4.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue in 2022
3.5 Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Head office and Area Served
3.6 Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Product and Application
3.7 Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Breakdown Data by Type
4.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Type (2024-2033)
5 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Breakdown Data by Application
5.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
6.2 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type
6.2.1 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033)
6.2.3 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
6.3 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application
6.3.1 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033)
6.3.3 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
6.4 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country
6.4.1 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
7.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type
7.2.1 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033)
7.2.3 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
7.3 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application
7.3.1 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033)
7.3.3 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
7.4 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country
7.4.1 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
8.2 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type
8.2.1 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023)
8.2.2 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033)
8.2.3 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
8.3 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application
8.3.1 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023)
8.3.2 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033)
8.3.3 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
9.2 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type
9.2.1 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033)
9.2.3 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
9.3 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application
9.3.1 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033)
9.3.3 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
9.4 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region
9.4.1 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 1ST Biotherapeutics
11.1.1 1ST Biotherapeutics Company Details
11.1.2 1ST Biotherapeutics Business Overview
11.1.3 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.1.4 1ST Biotherapeutics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.1.5 1ST Biotherapeutics Recent Developments
11.2 3B Pharmaceuticals
11.2.1 3B Pharmaceuticals Company Details
11.2.2 3B Pharmaceuticals Business Overview
11.2.3 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.2.4 3B Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.2.5 3B Pharmaceuticals Recent Developments
11.3 3D-Micromac
11.3.1 3D-Micromac Company Details
11.3.2 3D-Micromac Business Overview
11.3.3 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.3.4 3D-Micromac Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.3.5 3D-Micromac Recent Developments
11.4 3DMed
11.4.1 3DMed Company Details
11.4.2 3DMed Business Overview
11.4.3 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.4.4 3DMed Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.4.5 3DMed Recent Developments
11.5 3D Systems
11.5.1 3D Systems Company Details
11.5.2 3D Systems Business Overview
11.5.3 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.5.4 3D Systems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.5.5 3D Systems Recent Developments
11.6 10X Genomics
11.6.1 10X Genomics Company Details
11.6.2 10X Genomics Business Overview
11.6.3 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.6.4 10X Genomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.6.5 10X Genomics Recent Developments
11.7 A*STAR Agency for Science
11.7.1 A*STAR Agency for Science Company Details
11.7.2 A*STAR Agency for Science Business Overview
11.7.3 A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.7.4 A*STAR Agency for Science Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.7.5 A*STAR Agency for Science Recent Developments
11.8 Technology and Research
11.8.1 Technology and Research Company Details
11.8.2 Technology and Research Business Overview
11.8.3 Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.8.4 Technology and Research Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.8.5 Technology and Research Recent Developments
11.9 A*STAR Institute of Microelectronics (IME)
11.9.1 A*STAR Institute of Microelectronics (IME) Company Details
11.9.2 A*STAR Institute of Microelectronics (IME) Business Overview
11.9.3 A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.9.4 A*STAR Institute of Microelectronics (IME) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.9.5 A*STAR Institute of Microelectronics (IME) Recent Developments
11.10 A2A Pharmaceuticals
11.10.1 A2A Pharmaceuticals Company Details
11.10.2 A2A Pharmaceuticals Business Overview
11.10.3 A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.10.4 A2A Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.10.5 A2A Pharmaceuticals Recent Developments
11.11 Abbvie
11.11.1 Abbvie Company Details
11.11.2 Abbvie Business Overview
11.11.3 Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.11.4 Abbvie Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.11.5 Abbvie Recent Developments
11.12 AbCellera
11.12.1 AbCellera Company Details
11.12.2 AbCellera Business Overview
11.12.3 AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.12.4 AbCellera Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.12.5 AbCellera Recent Developments
11.13 ABL Bio
11.13.1 ABL Bio Company Details
11.13.2 ABL Bio Business Overview
11.13.3 ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.13.4 ABL Bio Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.13.5 ABL Bio Recent Developments
11.14 Abpro
11.14.1 Abpro Company Details
11.14.2 Abpro Business Overview
11.14.3 Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.14.4 Abpro Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.14.5 Abpro Recent Developments
11.15 Academy of Military Medical Sciences (China)
11.15.1 Academy of Military Medical Sciences (China) Company Details
11.15.2 Academy of Military Medical Sciences (China) Business Overview
11.15.3 Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.15.4 Academy of Military Medical Sciences (China) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.15.5 Academy of Military Medical Sciences (China) Recent Developments
11.16 Accellix
11.16.1 Accellix Company Details
11.16.2 Accellix Business Overview
11.16.3 Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.16.4 Accellix Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.16.5 Accellix Recent Developments
11.17 Accord Healthcare
11.17.1 Accord Healthcare Company Details
11.17.2 Accord Healthcare Business Overview
11.17.3 Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.17.4 Accord Healthcare Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.17.5 Accord Healthcare Recent Developments
11.18 AccuGenomics
11.18.1 AccuGenomics Company Details
11.18.2 AccuGenomics Business Overview
11.18.3 AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.18.4 AccuGenomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.18.5 AccuGenomics Recent Developments
11.19 ACEA Biosciences
11.19.1 ACEA Biosciences Company Details
11.19.2 ACEA Biosciences Business Overview
11.19.3 ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.19.4 ACEA Biosciences Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.19.5 ACEA Biosciences Recent Developments
11.20 AC Immune
11.20.1 AC Immune Company Details
11.20.2 AC Immune Business Overview
11.20.3 AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.20.4 AC Immune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.20.5 AC Immune Recent Developments
11.21 Acoustic MedSystems
11.21.1 Acoustic MedSystems Company Details
11.21.2 Acoustic MedSystems Business Overview
11.21.3 Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.21.4 Acoustic MedSystems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.21.5 Acoustic MedSystems Recent Developments
11.22 Adaptimmune
11.22.1 Adaptimmune Company Details
11.22.2 Adaptimmune Business Overview
11.22.3 Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.22.4 Adaptimmune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.22.5 Adaptimmune Recent Developments
11.23 Aduro BioTech
11.23.1 Aduro BioTech Company Details
11.23.2 Aduro BioTech Business Overview
11.23.3 Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.23.4 Aduro BioTech Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.23.5 Aduro BioTech Recent Developments
11.24 Advaxis
11.24.1 Advaxis Company Details
11.24.2 Advaxis Business Overview
11.24.3 Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.24.4 Advaxis Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.24.5 Advaxis Recent Developments
11.25 Adventus Ventures
11.25.1 Adventus Ventures Company Details
11.25.2 Adventus Ventures Business Overview
11.25.3 Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.25.4 Adventus Ventures Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.25.5 Adventus Ventures Recent Developments
11.26 Aerolase
11.26.1 Aerolase Company Details
11.26.2 Aerolase Business Overview
11.26.3 Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.26.4 Aerolase Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.26.5 Aerolase Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Asset purchase
Table 3. Key Players of Assignment
Table 4. Key Players of Co-development
Table 5. Key Players of Co-market
Table 6. Key Players of Co-promotion
Table 7. Key Players of Collaborative R&D
Table 8. Key Players of Contract service
Table 9. Key Players of CRADA
Table 10. Key Players of Cross-licensing
Table 11. Key Players of Others
Table 12. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 13. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2018-2023)
Table 16. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 17. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2024-2033)
Table 18. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Trends
Table 19. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Drivers
Table 20. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Challenges
Table 21. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Restraints
Table 22. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 23. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Share by Players (2018-2023)
Table 24. Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics as of 2022)
Table 25. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 26. Global 5 Largest Players Market Share by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 27. Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Headquarters and Area Served
Table 28. Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Product and Application
Table 29. Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Product and Application
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 32. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2018-2023)
Table 33. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 34. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2024-2033)
Table 35. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 36. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Share by Application (2018-2023)
Table 37. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 38. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Share by Application (2024-2033)
Table 39. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 40. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 41. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 42. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 43. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 47. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 48. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 49. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 50. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 51. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 52. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 53. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 54. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 55. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 56. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 59. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 61. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 62. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 63. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 68. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 69. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 70. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 71. 1ST Biotherapeutics Company Details
Table 72. 1ST Biotherapeutics Business Overview
Table 73. 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 74. 1ST Biotherapeutics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 75. 1ST Biotherapeutics Recent Developments
Table 76. 3B Pharmaceuticals Company Details
Table 77. 3B Pharmaceuticals Business Overview
Table 78. 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 79. 3B Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 80. 3B Pharmaceuticals Recent Developments
Table 81. 3D-Micromac Company Details
Table 82. 3D-Micromac Business Overview
Table 83. 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 84. 3D-Micromac Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 85. 3D-Micromac Recent Developments
Table 86. 3DMed Company Details
Table 87. 3DMed Business Overview
Table 88. 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 89. 3DMed Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 90. 3DMed Recent Developments
Table 91. 3D Systems Company Details
Table 92. 3D Systems Business Overview
Table 93. 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 94. 3D Systems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 95. 3D Systems Recent Developments
Table 96. 10X Genomics Company Details
Table 97. 10X Genomics Business Overview
Table 98. 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 99. 10X Genomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 100. 10X Genomics Recent Developments
Table 101. A*STAR Agency for Science Company Details
Table 102. A*STAR Agency for Science Business Overview
Table 103. A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 104. A*STAR Agency for Science Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 105. A*STAR Agency for Science Recent Developments
Table 106. Technology and Research Company Details
Table 107. Technology and Research Business Overview
Table 108. Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 109. Technology and Research Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 110. Technology and Research Recent Developments
Table 111. A*STAR Institute of Microelectronics (IME) Company Details
Table 112. A*STAR Institute of Microelectronics (IME) Business Overview
Table 113. A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 114. A*STAR Institute of Microelectronics (IME) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 115. A*STAR Institute of Microelectronics (IME) Recent Developments
Table 116. A2A Pharmaceuticals Company Details
Table 117. A2A Pharmaceuticals Business Overview
Table 118. A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 119. A2A Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 120. A2A Pharmaceuticals Recent Developments
Table 121. Abbvie Company Details
Table 122. Abbvie Business Overview
Table 123. Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 124. Abbvie Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 125. Abbvie Recent Developments
Table 126. AbCellera Company Details
Table 127. AbCellera Business Overview
Table 128. AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 129. AbCellera Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 130. AbCellera Recent Developments
Table 131. ABL Bio Company Details
Table 132. ABL Bio Business Overview
Table 133. ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 134. ABL Bio Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 135. ABL Bio Recent Developments
Table 136. Abpro Company Details
Table 137. Abpro Business Overview
Table 138. Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 139. Abpro Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 140. Abpro Recent Developments
Table 141. Academy of Military Medical Sciences (China) Company Details
Table 142. Academy of Military Medical Sciences (China) Business Overview
Table 143. Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 144. Academy of Military Medical Sciences (China) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 145. Academy of Military Medical Sciences (China) Recent Developments
Table 146. Accellix Company Details
Table 147. Accellix Business Overview
Table 148. Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 149. Accellix Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 150. Accellix Recent Developments
Table 151. Accord Healthcare Company Details
Table 152. Accord Healthcare Business Overview
Table 153. Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 154. Accord Healthcare Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 155. Accord Healthcare Recent Developments
Table 156. AccuGenomics Company Details
Table 157. AccuGenomics Business Overview
Table 158. AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 159. AccuGenomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 160. AccuGenomics Recent Developments
Table 161. ACEA Biosciences Company Details
Table 162. ACEA Biosciences Business Overview
Table 163. ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 164. ACEA Biosciences Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 165. ACEA Biosciences Recent Developments
Table 166. AC Immune Company Details
Table 167. AC Immune Business Overview
Table 168. AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 169. AC Immune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 170. AC Immune Recent Developments
Table 171. Acoustic MedSystems Company Details
Table 172. Acoustic MedSystems Business Overview
Table 173. Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 174. Acoustic MedSystems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 175. Acoustic MedSystems Recent Developments
Table 176. Adaptimmune Company Details
Table 177. Adaptimmune Business Overview
Table 178. Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 179. Adaptimmune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 180. Adaptimmune Recent Developments
Table 181. Aduro BioTech Company Details
Table 182. Aduro BioTech Business Overview
Table 183. Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 184. Aduro BioTech Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 185. Aduro BioTech Recent Developments
Table 186. Advaxis Company Details
Table 187. Advaxis Business Overview
Table 188. Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 189. Advaxis Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 190. Advaxis Recent Developments
Table 191. Adventus Ventures Company Details
Table 192. Adventus Ventures Business Overview
Table 193. Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 194. Adventus Ventures Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 195. Adventus Ventures Recent Developments
Table 196. Aerolase Company Details
Table 197. Aerolase Business Overview
Table 198. Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 199. Aerolase Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 200. Aerolase Recent Developments
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Asset purchase Features
Figure 4. Assignment Features
Figure 5. Co-development Features
Figure 6. Co-market Features
Figure 7. Co-promotion Features
Figure 8. Collaborative R&D Features
Figure 9. Contract service Features
Figure 10. CRADA Features
Figure 11. Cross-licensing Features
Figure 12. Others Features
Figure 13. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application: 2022 VS 2033
Figure 15. Industry sector Case Studies
Figure 16. Therapy areas Case Studies
Figure 17. Technology type Case Studies
Figure 18. Deal components Case Studies
Figure 19. Financial terms Case Studies
Figure 20. Stage of development Case Studies
Figure 21. Others Case Studies
Figure 22. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Report Years Considered
Figure 23. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 24. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 25. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region: 2022 VS 2033
Figure 26. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Players in 2022
Figure 27. Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics as of 2022)
Figure 28. The Top 10 and 5 Players Market Share by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue in 2022
Figure 29. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
Figure 31. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
Figure 32. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 33. United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Canada Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 36. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
Figure 37. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
Figure 38. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 39. Germany Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. France Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. U.K. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Italy Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Russia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Nordic Countries Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 46. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
Figure 47. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
Figure 48. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
Figure 50. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
Figure 51. Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2018-2033)
Figure 52. Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. South Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. China Taiwan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Australia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 59. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type (2018-2033)
Figure 60. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application (2018-2033)
Figure 61. Middle East, Africa, and Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 62. Brazil Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 63. Mexico Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 64. Turkey Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 65. Saudi Arabia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 66. Israel Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 67. GCC Countries Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 68. 1ST Biotherapeutics Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 69. 3B Pharmaceuticals Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 70. 3D-Micromac Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 71. 3DMed Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 72. 3D Systems Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 73. 10X Genomics Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 74. A*STAR Agency for Science Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 75. Technology and Research Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotec